Vesugen

ExperimentalShort Peptide Bioregulator (Vascular Research)Experimental

Vesugen is a short vascular bioregulator peptide commonly referenced as KED (Lys Glu Asp) and used in research contexts exploring endothelial signaling, vessel function, and circulatory markers.

Calculate Dose

For research use only.

Key Facts

CAS: —
Molecular Weight (MW): ≈390.4 g/mol
Half-life: Not established (limited public PK data; primarily research context)
Unit: mg
Administration Route: Oral or sublingual (common commercial formats); injectable research use exists by supplier
Frequency: Once daily (typical research pattern)
Last updated: 3/1/2026
Targets: Endothelial regulatory pathwaysVascular smooth muscle signaling (proposed)

Overview

Vesugen is a short vascular bioregulator peptide commonly referenced as KED (Lys Glu Asp) and used in research contexts exploring endothelial signaling, vessel function, and circulatory markers.

Protocol

Dosage Range: 5-20 mg daily (research context; not clinically established)
Frequency: Once daily (typical research pattern)
Cycle: 10-30 days common in bioregulator protocols (research context)
Administration Route: Oral or sublingual (common commercial formats); injectable research use exists by supplier
Reconstitution Guide: If lyophilized: reconstitute with bacteriostatic water per lab SOP (research only)

Science

Mechanism of Action

Proposed to modulate gene expression and cellular signaling in vascular tissue, supporting endothelial function and vessel wall homeostasis in experimental models.

Targets

Endothelial regulatory pathwaysVascular smooth muscle signaling (proposed)

Studies

— Journal/year not available
— Journal/year not available

Benefits

Studied for vascular and capillary supportProposed endothelial function support (research context)Circulatory function research applicationsVessel wall homeostasis and elasticity research